How is the Nautilus Biotechnology Inc today?

The Nautilus Biotechnology Inc today is trading in the down by -1.41% at 0.70.

How has Nautilus Biotechnology Inc performed historically?

The Nautilus Biotechnology Inc is currently trading down -1.41% on an intraday basis in the past week the index fell -9.09%. The index has been down -36.94% in the past quarter and fell -72.66% in the past year. You can view this in the overview section.

What is Nautilus Biotechnology Inc Annual Net Profit?

Nautilus Biotechnology Inc Annual Net Profit fell 11.16% in the last year to $70.78 M. Its sector's average net profit growth for the last fiscal year was -13.89%.

What is Nautilus Biotechnology Inc Price to Earning Ratio?

Nautilus Biotechnology Inc Price to Earning Ratio is -1.29, which is negative.

What is Nautilus Biotechnology Inc Stock Price?

Nautilus Biotechnology Inc Stock Price fell 72.66% and underperformed its sector by 97.47% in the past year.

What is Nautilus Biotechnology Inc Quarterly Net profit?

Nautilus Biotechnology Inc Quarterly Net profit rose 11.3% YoY to $16.61 M. Its sector's average net profit growth YoY for the quarter was -238.55%.

What is Nautilus Biotechnology Inc Debt to Equity Ratio?

Nautilus Biotechnology Inc Debt to Equity Ratio of 0.15 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Nautilus Biotechnology Inc Return on Equity(ROE)?

Nautilus Biotechnology Inc Return on Equity(ROE) for the last financial year was -29.86%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Nautilus Biotechnology Inc Mutual Fund Holding?

Nautilus Biotechnology Inc Mutual Fund Holding decreased by 0.24% in the last quarter to 7.81.

What is Nautilus Biotechnology Inc Institutional Holding?

Nautilus Biotechnology Inc Institutional Holding decreased by 0.9% in the last quarter to 36.81.

MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : BIOTECH
NAUTILUS BIOTECHNOLOGY INC

Nautilus Biotechnology Inc XNAS: NAUT

Nautilus Biotechnology Inc Live Share Price Today, Share Analysis and Chart

Name: Nautilus Biotechnology Inc: Is Infosys Ltd. worth buying?
Item: Nautilus Biotechnology Inc
Rating: 0.82133325
Author: Trendlyne DVM scores

about

Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the pr...

0.70 -0.01 (-1.41%)

77.35% Fall from 52W High

160.5K

XNAS Volume

XNAS 13 Jun, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

14.8 / 100

Technically Bearish

18.0 / 100

No estimates available

Nautilus Biotechnology Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Nautilus Biotechnology Inc Live Share Price Today, Share Analysis and Chart

Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the pr...

77.35% Fall from 52W High

SWOT Analysis

Nautilus Biotechnology Inc Live Price Chart

Nautilus Biotechnology Inc FAQ

How is Nautilus Biotechnology Inc today?

Nautilus Biotechnology Inc today is trading in the red, and is down by -1.41% at 0.70.

How has Nautilus Biotechnology Inc performed historically?

Nautilus Biotechnology Inc is currently trading down -1.41% on an intraday basis. In the past week the stock fell -9.09%. stock has been down -36.94% in the past quarter and fell -72.66% in the past year. You can view this in the overview section.